Biotech / Pharma
IPremom
Biotech / Pharma
Spanish developer IPremom, which has developed a molecular diagnostics platform for early prediction of pregnancy complications, received a €15 million seed investment led by Amadeus Capital Partners and Asabys Partners.
Founded
Region
Investors
People